Pharmacokinetic Study of Testosterone Enanthate

NCT01887418 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: QuickShot™ - 50 mg Treatment B
DRUG: QuickShot™ - 100 mg Treatment A
DRUG: Delatestryl 200 mg IM Treatment C

Sponsor

Antares Pharma Inc.